10 High Growth Canadian Stocks to Buy Now

7. Bausch + Lomb Corporation (NYSE:BLCO)

Expected 5-year EPS Growth: 39.78%

On April 16, Bausch + Lomb Corporation (NYSE:BLCO) announced that its ONE by ONE Recycling program, developed in collaboration with TerraCycle, has now collected and recycled more than 119.7 million units of used contact lenses, eye care products, and lens care materials in the United States. That milestone highlights the company’s growing leadership in sustainability and customer engagement, areas that increasingly matter to both consumers and institutional investors. Programs like this can strengthen brand loyalty while differentiating Bausch + Lomb in a competitive healthcare market.

Earlier, on April 8, Bausch + Lomb Corporation (NYSE:BLCO) announced that the U.S. Food and Drug Administration granted 510(k) clearance for the Bi-Blade+ advanced dual-port vitrectomy cutter and the Adaptive Fluidics advanced update for the Stellaris Elite Vision Enhancement System. These approvals reinforce Bausch + Lomb’s innovation pipeline in surgical ophthalmology, where new technologies can drive premium pricing and deepen surgeon adoption.

Bausch + Lomb Corporation (NYSE:BLCO) was founded in 1853 and is headquartered in Vaughan, Canada, the company develops, manufactures, and markets a broad portfolio of contact lenses, lens care solutions, ophthalmic pharmaceuticals, surgical devices, and vision-care products. Its scale and trusted brand provide meaningful competitive advantages in a steadily growing healthcare category driven by aging populations and rising rates of myopia and dry eye disease.